Title: Post COVID-19 MSSA pneumonia


Abstract should give clear indication of the objectives, scope, results, methods used, and conclusion of your work. One figure and one table can be included in your results and discussions. Coronavirus disease 2019 (COVID-19) was first identified at the hand of 2019 has a cluster of pneumonia cases in Wuhan, China. By February 2020, the virus quickly spread, becoming a global pandemic. The spectrum of a symptomatic infection severity can range from mild, severe, and critical disease. Many correlated comorbidities where established, including smoking, socioeconomic background, gender (Male prevalence), hypertension, obesity, cardiovascular disease, chronic lung disease, diabetes mellitus, cancer, and chronic kidney disease. In an extensive literature search, post-COVID-19 housing staphylococcus aureus pneumonia with pneumothorax has not been recorded. We present a case about a 62-year old male who presented with symptoms of COVID-19 with many underlying comorbidities, including hypertension and hyperlipidemia. He was on ventilator support during his first week in the hospital and then received supplemental oxygenation as he recovered from his COVID-19 pneumonia. Nearly a month and a half after his initial presentation he quickly decompensated and was started on supplemental oxygen and necessary treatments. It was then, with aid of lab work and imaging, daddy we determined that he had developed necrotizing Staphylococcus aureus pneumonia with pneumothorax. He was adequately treated, and once he was stable, he was discharged home and was told to continue his therapy.